Skip to main content

Durch Bluttransfusionen übertragbare Infektionskrankheiten

  • Chapter

Zusammenfassung

Obwohl die Zahl der durch Bluttransfusionen übertragbaren pathogenen Mikroorganismen groß ist, führen nur wenige beim Empfänger zu einem gehäuften Auftreten von Erkrankungen, die eine regelmäßige Untersuchung aller Blutkonserven erfordern. Zweifellos stellt die in den Richtlinien für die Bluttransfusion [66] geforderte sorgfältige Blutspenderauswahl, die sich auf Anamnese, körperliche Untersuchung und Laboruntersuchungen stützt, die wirkungsvollste Maßnahme zur Qualitätssicherung von Blutkonserven dar. Durch diese Vorauswahl wird das Risiko einer Übertragung von Infektionskrankheiten wesentlich vermindert.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, Edwards VM, Werch J (1981) Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The Transfusion-Transmitted Viruses Study. New Engl J Med 304:989–994.

    Article  PubMed  CAS  Google Scholar 

  2. Alter HJ (1984) Resolved and unresolved issues in non-A, non-B hepatitis. In: Williams R, Mad-drey WC (eds) Butterworths International Medical Reviews Gastroenterology 4: Liver, Butter-worths, London, pp 165–190.

    Google Scholar 

  3. Alter HJ (1985) Posttransfusion hepatitis: Clinical features, risk and donor testing. In: Dodd RY, Barker LF (eds) Progress in Clinical and Biological Research Vol. 182: Infection, Immunity and Blood Transfusion, Alan R Liss, New York, pp 47–61.

    Google Scholar 

  4. Anonymous (1986) Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III, lymph-adenopathy-associated virus infection. MMWR 35/14:231–233.

    Google Scholar 

  5. Barbara J, Salker R, Lalji F, Mochnaty P (1982) TPHA compared with cardiolipin tests for serological detection of early primary syphilis. J Clin Path 35:1394–1395.

    Article  PubMed  CAS  Google Scholar 

  6. Barin F, McLane MF, Allen JS, Lee TH, Groop-man JE, Essex M (1985) Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science 228:1094–1096.

    Article  PubMed  CAS  Google Scholar 

  7. Beeson PB, (1943) Jaundice occurring one to four months after transfusion of blood or plasma JAMA 121:1332–1334.

    Google Scholar 

  8. Ben-Porath E, Wands JR, Bar-Shany S, Huggins C, Isselbacher K, (1985) Improved detection of hepatitis B surface antigen (HBsAg) in blood donors by monoclonal radioimmunoassay. Transfusion 25:10–14.

    Article  PubMed  CAS  Google Scholar 

  9. Bird GWG, Menon KK (1961) Survival of microfilaria bancrofti in stored blood. Lancet 1:721–722.

    Article  Google Scholar 

  10. Braude AI, Sanford JP, Bartlett JE (1952) Effects and clinical significance of bacterial contaminants in transfused blood. J Lab Clin Med 39:902–916.

    PubMed  CAS  Google Scholar 

  11. Braude AI, Carey FJ, Sieminski J (1955) Studies on bacterial transfusion reactions from refrigerated blood: The properties of cold-growing bacteria. J Clin Invest 34:311–325.

    Article  PubMed  CAS  Google Scholar 

  12. Bruce-Chwatt LJ (1982) Transfusion malaria revisited. Trop Dis Bull 79:827–840.

    PubMed  CAS  Google Scholar 

  13. Bruce-Chwatt LJ (1985) Transfusion associated parasitic infections. In: Dodd RY, Barker LF (eds) Progress in Clinical and Biological Research Vol 182: Infection, Immunity and Blood Transfusion, Alan R Liss, New York, pp 101–125.

    Google Scholar 

  14. Bruce-Chwatt LJ (1985) Transfusion malaria. Lancet 11:271.

    Article  Google Scholar 

  15. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey MA, Santos-Ferreira L, Laurent AG, Dau-guet C, Katlama C, Rouzioux C, Klatzmann D, Champalimaud JL, Montagnier L (1986) Isolation of a new human retrovirus from West African patients with AIDS. Science 233:343–346.

    Article  PubMed  CAS  Google Scholar 

  16. Coffin J, Haase A, Levy JA, Montagnier L, Orosz-lan S, Teich N, Temin H, Toyoshima K, Varmus H, Vogt P, Weiss R (1986) Human immunodeficiency viruses (Letter). Science 232:697.

    Article  PubMed  CAS  Google Scholar 

  17. Contreras M (1984) Necessary tests on blood donations to detect infectious agents. Vox Sang suppl 1, 46:83–88.

    Article  Google Scholar 

  18. Cossart YE, Kirsch S, Ismay SL (1982) Post-transfusion hepatitis in Australia: Report of the Australian Red Cross study. Lancet 1.208–213.

    Article  PubMed  CAS  Google Scholar 

  19. Cossart YE, Field AM, Cant B, Widdows D (1975) Parvo-viruslike particles in human sera. Lancet 1:72–73.

    Article  PubMed  CAS  Google Scholar 

  20. Couroucé AM, Ferchal F, Morinet F, Muller A, Drouet J, Soulier JP, Perol Y (1984) Human parvovirus infections in France. Lancet 1:21.

    Google Scholar 

  21. Desmyter J (1986) AIDS and blood transfusion. Vox Sang 51:21.

    Article  PubMed  Google Scholar 

  22. Dienstag JL, Stevens CE, Szmuness W (1981) The epidemiology of non-A, non-B hepatitis: Emerging patterns. In: Gerety RJ (ed) Non-A, non-B Hepatitis, Academic Press, New York, pp 119–138.

    Google Scholar 

  23. Doerr HW, Braun R, Munk K (1985) Human cytomegalovirus infection: Recent developments in diagnosis and epidemiology. Klin Wschr 63:241–251.

    Article  PubMed  CAS  Google Scholar 

  24. Feinman SV, Berris B, Sinclair JC, Wrobel DM, Murphy BL, Maynard JE (1975) E-antigen and anti-e in HBsAg carriers. Lancet 11:1173–1174.

    Article  Google Scholar 

  25. Greenwalt TJ (1985) Summary and Closing. In: Dodd RY, Barker LF (eds) Progress in Clinical and Biological Research Vol 182: Infection, Immunity and Blood Transfusion, Alan R Liss, New York, pp 445–449.

    Google Scholar 

  26. Heimburger N, Schwinn H, Gratz P, Lüben G, Kumpe G, Herchenhan B (1981) Faktor VIII-Konzentrat, hochgereinigt und in Lösung erhitzt. Arzneim.-Forsch./Drug Res 31:619–622.

    CAS  Google Scholar 

  27. Henle W, Henle G (1985) Epstein-Barr-virus and blood transfusions. In: Dodd RY, Barker LF (eds) Progress in Clinical and Biological Research Vol. 182: Infection, Immunity and Blood Transfusion, Alan R Liss, New York, pp 201–209.

    Google Scholar 

  28. Janitschke K (1984) Parasitosen. In: Thomas L (ed) Labor und Diagnose 2. Aufl. Med Verlagsges, Marburg/L, pp 912–922.

    Google Scholar 

  29. Kalyanaraman VS, Sarngadharan MG, Nakao Y, Ito Y, Aoki T, Gallo RC (1982) A new subtype of human T-cell leukemia virus (HTLVII) associated with a T-cell variant of hairy cell leukemia. Science 215:571–573.

    Article  Google Scholar 

  30. Kanki PJ, Barin F, M’Boup S, Denis F, Essex M (1986) The family of T-lymphotropic viruses in primates and humans. Abstr Vol 2nd Int Conf on AIDS, Paris, p 6.

    Google Scholar 

  31. Katchaki JN, Siem TH, Brouwer R, van Loon AM, van der Logt JThM (1981) Posttransfusion non-A, non-B hepatitis in the Netherlands. Brit Med J 282:107–108.

    Article  CAS  Google Scholar 

  32. Koziol DE, Holland PV, Alling DW, Melpolder JC, Solomon RE, Purcell RH, Hudson LM, Shoup FJ, Krakauer H, Alter HJ (1986) Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Int Med 104:488–495.

    Article  PubMed  CAS  Google Scholar 

  33. Kubanek B, Koerner K (1986) Häufigkeit von HTLV-III-Antikörpern bei Blutspendern des Deutschen Roten Kreuzes, DMW 111:516–517.

    CAS  Google Scholar 

  34. Kühnl P, Seidl S, Holzberger G (1985) HLA-DR4 antibodies cause positive HTLV-III antibody ELISA results. Lancet 11:1222–1223.

    Article  Google Scholar 

  35. Kühnl P, Seidl S, Ray V, Kulkarni AG, Mba EC, Chandanayingyong D (1987) HIV antibody screening in blood donors from India, Nigeria and Thailand. Vox Sang 52:203–205.

    Article  PubMed  Google Scholar 

  36. Lamberson HV (1985) Cytomegalovirus (CMV): The agent, its pathogenesis, and its epidemiology. In: Dodd RY, Barker LF (eds) Progress in Clinical and Biological Research Vol. 182:Infection, Immunity and Blood Transfusion, Alan R Liss, New York, pp 149–173.

    Google Scholar 

  37. Lawrence CN, Lui KJ, Peterman TA, Jaffe HW, Jason JM, Allen JR (1986) Characteristics of incubation periods (IP) in pediatric cases of transfusion-associated acquired immunodeficiency syndrome (TA-AIDS). Abstr Vol 2nd Int Conf on AIDS, Paris, p 33.

    Google Scholar 

  38. Martini GA (1949) Die homologe Serumhepatitis. Deutsche Med Wschr 74:568–572.

    Article  Google Scholar 

  39. Martini GA (1980) Round table discussion: Non-A, non-B hepatitis. In: Bianchi L, Gerok W, Sik-kinger K, Stalder GA (eds) Virus and the Liver MTP Press Lancaster pp 305–310.

    Google Scholar 

  40. McCray E and the Cooperative Needlestick Sur-, veillance Group (1986) Occupational risk of the acquired immunodeficiency syndrome among health care workers. New Engl J Med 314:1127–1130.

    Article  PubMed  CAS  Google Scholar 

  41. Nath D, Fang CT, Berberian H, Bastiaans MJ, Dodd RY, Sandler GS, Barker LF (1980) Hepatitis-associated markers in the American Red Cross volunteer blood donor population. II.Distribution of level of HBsAg reactivity by radioimmunoassay and occurrence of nonspecific reactivity. Vox Sang 39:73–78.

    Article  PubMed  CAS  Google Scholar 

  42. Okochi K, Sato H (1985) Adult T-cell leukemia virus, blood donors and transfusion: Experience in Japan. In: Dodd RY, Barker LF (eds) Progress in Clinical and Biological Research Vol 182: Infection, Immunity and Blood Transfusion, Alan R Liss, New York, pp 245–256.

    Google Scholar 

  43. Peterman TA (1987) Transfusion-associated acquired immunodeficiency syndrome. World J Surg 11:36–40.

    Article  Google Scholar 

  44. Prince AM, Horowitz B, Brotman B (1986) Sterilisation of hepatitis and HTLV-III viruses by exposure to tri (n-butyl) phosphate and sodium cho-late, Lancet 1:706–710.

    Article  PubMed  CAS  Google Scholar 

  45. Raimondo G, Sneedile A, Gallo L, Balbo A, Pon-zetto A, Rizzetto M (1982) Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. Lancet 1:249–251.

    Article  PubMed  CAS  Google Scholar 

  46. Rizzetto M, Canese MG, Arico S, Crivelli O, Trepo C, Bonino F, Verme G (1977) Immunofluorescence detection of a new antigen/antibody system (delta/anti-delta) associated with hepatitis B virus in liver and serum of HBsAg carriers. Gut 18:997–1003.

    Article  PubMed  CAS  Google Scholar 

  47. Rodgers-Johnson P, Gajdusek DC, Morgan OSC, Zaninovic V, Sarin PS, Graham DS (1986) HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet 11:1247–1248.

    Google Scholar 

  48. Roth JA, Siegel SE, Levine AS (1971) Fatal recurrent toxoplasmosis in a patient initially infected via a leukocyte transfusion. Am J Clin Path 56:601–605.

    PubMed  CAS  Google Scholar 

  49. Ruebush TK (1980) Human babesiosis in North America. Trans Roy Soc Trop Med Hyg 74:149–152.

    Article  PubMed  Google Scholar 

  50. Sarngadharan MG, Popovic ML, Bruch L, Schiip-bach J, Gallo RC (1984) Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 224:506–508.

    Article  PubMed  CAS  Google Scholar 

  51. Schmunis GA (1985) Chagas’ disease and blood transfusion. In: Dodd RY, Barker LF (eds) Progress in Clinical and Biological Research Vol 182: Infection, Immunity and Blood Transfusion, Alan R Liss, New York, pp 127–145.

    Google Scholar 

  52. Seidl S (1983) Hepatitis associated with transfusion and substitution therapy: An introduction. In: Overby LR, Deinhardt F, Deinhardt J (eds) Viral Hepatitis, 2nd Int Max von Pettenkofer Symposium, M Dekker, New York-Basel, pp 213–216.

    Google Scholar 

  53. Seidl S, Trautmann L (1981) Detection of HBsAg in blood donors. Rev Franc Transf Immunohe-matol 24:319–335.

    Article  CAS  Google Scholar 

  54. Seto B, Coleman W, Iwarson S, Gerety RJ (1984) Detection of reverse transcriptase activity in association with the non-A, non-B hepatitis agent(s). Lancet 11:941–943.

    Article  Google Scholar 

  55. Siegel SE, Lunde MN, Gelderman AH (1971) Transmission of toxoplasmosis by leukocyte transfusion. Blood 37:388–394.

    PubMed  CAS  Google Scholar 

  56. Soulier JP (1984) Diseases transmissible through blood. Vox Sang 47:1–6.

    Article  PubMed  CAS  Google Scholar 

  57. Spichtin HP (1985) Hepatitis non-A, non-B (HNANB): Epidemiologische, klinische, serologische und morphologische Aspekte. Klin Wschr 63:389–404.

    Article  PubMed  CAS  Google Scholar 

  58. Stephan W (1982) Fractionation of cold-sterilized plasma. A new concept in production of non-infectious plasma proteins. Arzneim-Forsch/Drug Res 32 (II), 8, 799–801.

    Google Scholar 

  59. Stevens CE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Kahn R, Werch J, Edwards V (1984) Relation of HBV antibody status of blood donors to the occurrence of non-A, non-B hepatitis in their recipients. Ann Int Med 101:733–738.

    Article  PubMed  CAS  Google Scholar 

  60. Sugg U (1986) Zum Problem der posttransfusio-nellen Hepatitis. Beitr. Infusionstherapie klin. Ernähr. 15: Transfusionsmedizin aktuell-Infektio-nen, Thrombozyten, Granulozyten, Karger, Basel, pp 30–38.

    Google Scholar 

  61. Sugg U, Schneider W, Hoffmeister HE, Huth Ch, Stephan W, Lissner R, Haase W (1985) Hepatitis B immunoglobulin to prevent non-A, non-B posttransfusion hepatitis. Lancet 1:406.

    Google Scholar 

  62. Tabor E (1982) Infectious complications of blood transfusion. Academic Press, New York-London pp 65–74.

    Google Scholar 

  63. Tateda A, Kikuchi K, Numazaki Y, Shirachi R, Ishida N (1979) Non-B hepatitis in Japanese recipients of blood transfusions: Clinical and serologic studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen. J Infect Dis 130:511–518.

    Article  Google Scholar 

  64. Taylor DM, Fraser H, Salacinski PR, Dickinson AG, Robertson PA, Lowry PJ (1985) Preparation of growth hormone free from contamination with unconventional slow viruses. Lancet 11:260–262.

    Article  Google Scholar 

  65. Van der Sluis JJ, Onvlee PC, Kothe FCHA, Vu-zevski VD, Aelbers GMN, Menke HE (1984) Transfusion syphilis, survival of Treponema pallidum in donor blood. I.Report of an orientating study. Vox Sang 47:197–204.

    Article  PubMed  Google Scholar 

  66. Wissenschaftlicher Beirat der Bundesärztekammer und Bundesgesundheitsamt: Richtlinien zur Blutgruppenbestimmung und Bluttransfusion (1984) BÄK Wissenschaftl. Schriftenreihe Bd. 3, Deutscher Ärzte-Verlag, Köln.

    Google Scholar 

  67. Wood EE (1955) Brucellosis as a hazard of blood transfusion Br Med J 1:27–28.

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Seidl, S., Kühnl, P. (1988). Durch Bluttransfusionen übertragbare Infektionskrankheiten. In: Mueller-Eckhardt, C. (eds) Transfusionsmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10601-3_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10601-3_30

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10602-0

  • Online ISBN: 978-3-662-10601-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics